Skip to main content

Table 1 Grades of recommendation, assessment, development, and evaluation summary of findings table

From: Higher versus lower positive end-expiratory pressure in patients without acute respiratory distress syndrome: a meta-analysis of randomized controlled trials

Certainty assessment

Summary of findings

Participants (studies)

Risk of bias

Inconsistency

Indirectness

Imprecision

Other considerations

Overall certainty of evidence

Higher PEEP (N/total or N)

Lower PEEP (N/total or N)

Relative effect (RR, MD or SMD, 95% CI) of higher PEEP

Hospital mortality

1502 (9 RCTs)

Very seriousa

Not serious

Not serious

Not serious

None

LOW

274/760 (36.1%)

259/742 (34.9%)

1.02 (0.89 to 1.16)

PaO2/FiO2

1444 (8 RCTs)

Seriousb

Seriousc

Not serious

Not serious

Strong association

MODERATE

732

712

50.46 mmHg (33.93 to 66.99)

Compliance

189 (3 RCTs)

Very seriousd

Not serious

Not serious

Not serious

None

LOW

101

88

8.46 mL/cmH2O (3.11 to 13.82)

Hypoxemia

1320 (5 RCTs)

Very seriouse

not Serious

Not serious

Not serious

None

LOW

121/667 (18.4%)

168/653 (25.7%)

0.60 (0.40 to 0.92)

Barotrauma

1372 (7 RCTs)

Very seriousf

Not serious

Not serious

Not serious

None

LOW

38/697 (5.5%)

52/675 (7.7%)

0.78 (0.55 to 1.11)

ARDS

1315 (6 RCTs)

Very seriousg

Not serious

Not serious

Not serious

None

LOW

28/672 (4.2%)

54/643 (8.4%)

0.50 (0.32 to 0.78)

Duration of ventilation

1510 (10 RCTs)

Very serioush

Seriousi

Not serious

Not serious

Publication bias strongly suspectedj

VERY LOW

771

739

− 0.03 (− 0.27 to 0.21)

Hospital stay

1245 (5 RCTs)

Seriousk

Not serious

Not serious

Not serious

None

MODERATE

629

616

− 0.02 (− 0.69 to 0.66)

  1. PEEP, positive end-expiratory pressure; N, number of patients; RR: risk ratio; MD, mean difference; SMD: standardized mean difference; CI, confidence interval; RCT, randomized controlled trials; PaO2/FiO2, arterial partial pressure of oxygen to fraction of inspired oxygen ratio; ARDS, acute respiratory distress syndrome. “Other considerations” include publication bias, large effect, plausible confounding, and dose response gradient
  2. aFive studies were at high risk of bias; four studies were at moderate risk of bias
  3. bSix studies were at moderate risk of bias; two studies were at high risk of bias
  4. cModerate heterogeneity (I2 = 59%) present across studies
  5. dThree studies were at high risk of bias
  6. eThree studies were at high risk of bias; two studies were at moderate risk of bias
  7. fFive studies were at high risk of bias; two studies were at moderate risk of bias
  8. gFour studies were at high risk of bias; two studies were at moderate risk of bias
  9. hSix studies were at high risk of bias; four studies were at moderate risk of bias
  10. iModerate heterogeneity (I2 = 65%) present across studies
  11. jVisual inspection of the funnel plot suggests that publication bias cannot be excluded
  12. kThree studies were at moderate risk of bias; two studies were at high risk of bias